11-63629402-A-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_015459.5(ATL3):āc.1543T>Gā(p.Ser515Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,461,378 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015459.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATL3 | NM_015459.5 | c.1543T>G | p.Ser515Ala | missense_variant | 13/13 | ENST00000398868.8 | NP_056274.3 | |
ATL3 | NM_001290048.2 | c.1489T>G | p.Ser497Ala | missense_variant | 13/13 | NP_001276977.1 | ||
ATL3 | XM_047426725.1 | c.1699T>G | p.Ser567Ala | missense_variant | 14/14 | XP_047282681.1 | ||
ATL3 | XM_006718493.2 | c.1486T>G | p.Ser496Ala | missense_variant | 12/12 | XP_006718556.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATL3 | ENST00000398868.8 | c.1543T>G | p.Ser515Ala | missense_variant | 13/13 | 1 | NM_015459.5 | ENSP00000381844 | ||
ATL3 | ENST00000538786.1 | c.1489T>G | p.Ser497Ala | missense_variant | 13/13 | 2 | ENSP00000437593 | P1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461378Hom.: 0 Cov.: 30 AF XY: 0.0000124 AC XY: 9AN XY: 727052
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Neuropathy, hereditary sensory, type 1F Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 11, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with ATL3-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with alanine at codon 515 of the ATL3 protein (p.Ser515Ala). The serine residue is weakly conserved and there is a moderate physicochemical difference between serine and alanine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.